- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.19: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.20: 5 residues within 4Å:- Chain A: N.122, A.123, T.124, N.125, V.127
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: E.132, N.164, N.165
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain A: T.108, N.234, T.236
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: N.280, E.281, N.282
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: N.331, P.579, Q.580
Ligand excluded by PLIPNAG.25: 5 residues within 4Å:- Chain A: F.338, G.339, F.342, N.343, L.368
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain A: N.709, I.1130, G.1131
- Chain H: D.796
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain H: Y.28, N.61
Ligand excluded by PLIPNAG.28: 5 residues within 4Å:- Chain H: N.122, A.123, T.124, N.125, V.127
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain H: E.132, N.164, N.165
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain H: T.108, N.234, T.236
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain H: N.280, E.281, N.282
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain H: N.331, P.579, Q.580
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain H: F.338, G.339, F.342, N.343, L.368
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain H: N.709, I.1130, G.1131
- Chain I: D.796
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain I: Y.28, N.61
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain I: N.122, A.123, T.124, N.125, V.127
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain I: E.132, N.164, N.165
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain I: T.108, N.234, T.236
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain I: N.280, E.281, N.282
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain I: N.331, P.579, Q.580
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain I: F.338, G.339, F.342, N.343
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain A: D.796
- Chain I: N.709, I.1130, G.1131
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhu, X. et al., Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies. Plos Biol. (2021)
- Release Date
- 2021-05-12
- Peptides
- Spike glycoprotein: AHI
Fab ab1 Heavy Chain: BFG
Fab ab1 Light Chain: CDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AH
BI
CB
DF
FG
HC
ED
GE
I
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhu, X. et al., Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies. Plos Biol. (2021)
- Release Date
- 2021-05-12
- Peptides
- Spike glycoprotein: AHI
Fab ab1 Heavy Chain: BFG
Fab ab1 Light Chain: CDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AH
BI
CB
DF
FG
HC
ED
GE
I